ESC 365 - Biomarkers in risk assessment: will they ever be ready for clinical practice?

ESC Premium Access

Biomarkers in risk assessment: will they ever be ready for clinical practice?

Session: Something old, something new: biomarkers and cardiovascular risk assessment

Topic: Cardiovascular Risk Assessment

Speaker: Assistant Professor N. Paynter (Boston, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Assistant Professor Nina Paynter

Boston (United States of America)

1 presentation

0 follower

4 more presentations in this session

State of the Art in biomarkers and cardiovascular risk assessment.

Speaker: Professor M. Kavousi (Rotterdam, NL)

Screening multiple biomarkers for associations with cardiovascular death in patients with stable coronary heart disease

Speaker: Professor L. Wallentin (Uppsala, SE)

Cardiovascular preoperative screening system for non-cardiac surgery modified from ACC/AHA guideline can provide effective evaluation.

Speaker: Doctor S. Taniai (Tokyo, JP)

Utility of high risk plaques detected by cardiac magnetic resonance for prediction of future coronary events adding on Framingham risk score in subjects without coronary artery disease.

Speaker: Doctor H. Miura (Osaka, JP)

Access the full session

Something old, something new: biomarkers and cardiovascular risk assessment

Speakers: Assistant Professor N. Paynter, Professor M. Kavousi, Professor L. Wallentin, Doctor S. Taniai, Doctor H. Miura

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources